文献速递功能神经外科

拉丁美洲与欧美真实世界人群脑深部电刺激比较:适应证、人口学、技术、设备与不良事件

Deep brain stimulation in Latin America in comparison with the US and Europe in a real-world population: indications, demographics, techniques, technology, and adverse events.
PubMed 文献 · J Neurosurg · 2024-07-12

基于美敦力产品监测登记截至2021年7月31日的数据,比较拉丁美洲与美国、欧洲脑深部电刺激的适应证、人口学、不良事件、技术与结局。拉丁美洲以帕金森病最常见、肌张力障碍居第二,植入时平均年轻10岁,可充电电池使用(72.37%)高于美国(6.44%)和欧洲(9.9%),分期手术比例(11.84%)低于美国(97.58%)和欧洲(34.86%)。

要点

  • 拉丁美洲脑深部电刺激最常见适应证为帕金森病,肌张力障碍为第二常见适应证。
  • 拉丁美洲患者植入时平均比美国、欧洲年轻10岁,可能与肌张力障碍患者较多有关。
  • 拉丁美洲可充电电池使用比例72.37%,高于美国6.44%和欧洲9.9%。

核心结论

  • 拉丁美洲脑深部电刺激的适应证、技术和设备与美国、欧洲相似,但可充电设备使用更普遍、手术患者更年轻,24个月随访时生活质量改善更持续。
  • 作者假设这些差异源于各区域资源差异,但需要更多研究来标准化全球脑深部电刺激实践。

研究设计与样本

  • 基于美敦力产品监测登记截至2021年7月31日数据的区域比较研究。
  • 拉丁美洲脑深部电刺激中心位于哥伦比亚3家、阿根廷1家、巴西1家、墨西哥1家。
  • 采用Fisher精确检验比较区域间分类变量比例差异,采用Wilcoxon符号秩检验比较EQ-5D指数评分自基线至随访的变化。

主要发现

  • 所有区域脑深部电刺激最常见适应证均为帕金森病;拉丁美洲第二常见为肌张力障碍,其他区域为特发性震颤。
  • 拉丁美洲患者脑深部电刺激植入时平均比美国、欧洲年轻10岁,最可能归因于接受植入的肌张力障碍患者更多。
  • 可充电电池在拉丁美洲占72.37%,显著高于美国6.44%和欧洲9.9%。
  • 分期手术在拉丁美洲仅占11.84%,低于美国97.58%和欧洲34.86%。
  • EQ-5D评分在所有区域术后6至12个月内均显著改善(p < 0.0001),但24个月随访仅拉丁美洲显示量表改善(p < 0.0001)。

关键数值与推荐

  • 可充电电池使用比例:拉丁美洲72.37% vs 美国6.44% vs 欧洲9.9%。
  • 分期手术比例:拉丁美洲11.84% vs 美国97.58% vs 欧洲34.86%。
  • EQ-5D评分术后6至12个月改善:所有区域p < 0.0001;24个月随访仅拉丁美洲p < 0.0001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需要更多研究来标准化全球脑深部电刺激实践,以改善患者生活质量和提供高质量照护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to provide geographic comparisons of deep brain stimulation (DBS) procedures in Latin America with the US and Europe regarding primary indications, demographic information, clinical and device-related adverse events, technology used, and patient outcomes using the Medtronic Product Surveillance Registry data as of July 31, 2021. METHODS: Two thousand nine hundred twelve patients were enrolled in the registry (2782 received DBS and 1580 are currently active). Fourteen countries contributed 44,100 years of device experience to the registry. DBS centers in Latin America are located in Colombia (n = 3), Argentina (n = 1), Brazil (n = 1), and Mexico (n = 1). Fisher's exact test was used to compare the difference in proportions of categorical variables between regions. The Wilcoxon signed-rank test was used for the EQ-5D index score change from baseline to follow-up. RESULTS: The most common indication for DBS was Parkinson's disease across all regions. In Latin America, dystonia was the second most common indication, compared to essential tremor in other regions. There was a striking finding with respect to age-patients were an average of 10 years younger at DBS implantation in Latin America. This difference was most likely due to the greater number of patients with dystonia receiving the device implants. The intraoperative techniques were quite similar, showing the same level of quality and covering the main principles of the surgeries with some variations in the brand of frames, planning software, and microrecording systems. Rechargeable batteries were significantly more common in Latin America (72.37%) than in the US (6.44%) and Europe (9.9%). Staging of the DBS procedure differed, with only 11.84% in Latin America staging the procedure compared with 97.58% and 34.86% in the US and Europe, respectively. The EQ-5D score showed significant improvements in all regions during the first 6-12 months (p < 0.0001). However, the 24-month follow-up only showed an improvement in the scale for Latin America (p < 0.0001). CONCLUSIONS: DBS was performed in Latin America with similar indications, techniques, and technology as in the US and Europe. Important differences were found, with Latin America implementing more regular use of rechargeable devices, including younger patients at the time of surgery, and showing more sustained quality of life improvements at 24 months of follow-up. The authors hypothesize that these disparities stem from differences in resources among regions. However, more studies are needed to standardize DBS practice across the world to improve patients' quality of life and provide high-quality care.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lopez Rios AL, Piedimonte F, Arango GJ, et al. Deep brain stimulation in Latin America in comparison with the US and Europe in a real-world population: indications, demographics, techniques, technology, and adverse events. J Neurosurg. 2024. PMID: 38996391. doi:10.3171/2024.4.JNS23924

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。